Broadly neutralizing human monoclonal antibodies against BK polyomavirus genotypes
Journal of General Virology · 2025
DOI: 10.1099/jgv.0.002197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Virology, 2025. Verfasst von J Andrew Duty und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Therapeutic Antibody Development, Drug Discovery Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10709, USA. Hauptthemen laut MEDLINE: BK Virus, Antibodies, Neutralizing, Antibodies, Viral, Antibodies, Monoclonal. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
BK polyomavirus (BKV) causes polyomavirus-associated nephropathy (BKV-nephropathy) and polyomavirus-associated haemorrhagic cystitis following kidney transplantation and allogeneic haematopoietic stem cell transplantation. BKV strains consist of four distinct genotypes (BKV-I, -II, -III and -IV), with more than 80% of individuals seropositive for the BKV-I genotype and lower prevalences of infection or co-infection with the other genotypes. BKV-nephropathy occurs widely in immunosuppressed transplant recipients, with the recommended treatment including reduction of immunosuppressive drugs. High serum titres of BKV-neutralizing antibodies and treatment with BKV-neutralizing intravenous immunoglobulin are associated with reduced levels of BKV-DNAemia in kidney transplant recipients, suggesting anti-BKV antibodies can limit viral load. Thus, we set out to generate broadly neutralizing human mAbs against the viral protein 1 (VP1) major capsid protein of BKV genotypes I–IV using VelocImmune ® transgenic mice that encode for human immunoglobulins. Hybridoma clones from VelocImmune ® mice immunized with combinations of BKV I–IV VP1 and respective genotypes of BKV pseudoviruses (BK-PsVs) were screened using a high-throughput binding assay against BKV-I VP1 expressed in HEK-293 cells. The VP1-binding hybridoma clones were then assessed for neutralization with BK-PsV consisting of respective VP1 proteins from BKV-I, -II, -III or -IV on the virion surface. Overall, 36 broadly cross-neutralizing mAbs against BKV-I, -II, -III and -IV were identified. Importantly, 20 of the cross-reactive immunoglobulins were subjected to nucleotide sequencing, resulting in 6 clonotype families with 14 genetically distinct immunoglobulins. Several of the most effective mAbs were fully humanized with the IgG1 Fc domain with broad neutralization of BK-PsV-I, -II, -III and -IV genotypes with IC50s ranging from ~7 to 200 pM. Thus, these cross-neutralizing mAbs represent potential biologics to be developed into BKV therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Therapeutic Antibody Development, Drug Discovery Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10709, USA.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10709, USA.
- Lab of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Förderung
- NIAID NIH HHS
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Duty, J. A., Kraus, T. A., Kumar, M., Tortorella, N. A., Jimoh, T. O., Barrall, E. B., Pastrana, D. V., Buck, C. B., Moran, T. M., & Tortorella, D. (2025). Broadly neutralizing human monoclonal antibodies against BK polyomavirus genotypes. Journal of General Virology. https://doi.org/10.1099/jgv.0.002197
Vancouver
Duty JA, Kraus TA, Kumar M, Tortorella NA, Jimoh TO, Barrall EB, et al. Broadly neutralizing human monoclonal antibodies against BK polyomavirus genotypes. Journal of General Virology. 2025. doi:10.1099/jgv.0.002197
BibTeX
@article{Duty2025,
author = {Duty, J Andrew and Kraus, Thomas A and Kumar, Madhu and Tortorella, Nicolo A and Jimoh, Tajudeen O and Barrall, Emma B and Pastrana, Diana V and Buck, Christopher B and Moran, Thomas M and Tortorella, Domenico},
title = {Broadly neutralizing human monoclonal antibodies against BK polyomavirus genotypes},
journal = {Journal of General Virology},
year = {2025},
doi = {10.1099/jgv.0.002197}
}
EUVIMED